US green light for Pfizer/Merck diabetes therapies

2nd January 2018 Uncategorised 0

Pfizer and Merck’s diabetes drugs Steglatro and Steglujan have been approved for the US market.

More: US green light for Pfizer/Merck diabetes therapies
Source: News